biblio

Export 8 results:
Filters: First Letter Of Last Name is G and Author is George, Christy P.  [Clear All Filters]
2024
S. Pahar, Sharma, V., K. Raj, V., Sangole, M. P., George, C. P., Singh, K., Vanka, K., Gonnade, R. G., and Sen, S. S., “Tridentate NacNac tames T-shaped nickel(I) radical”, Chemistry- a european journal, vol. 30, no. 12, 2024.
2023
S. K. Rai, Tothadi, S., Arhangelskis, M., George, C. P., Gonnade, R. G., and Nangia, A. K., “Polymorph II of hydroxyurea 150 years after its first synthesis”, Crystengcomm, vol. 25, no. 18, pp. 2712-2716, 2023.
P. S. Shaligram, George, C. P., Sharma, H., Mahadik, K. R., Patil, S., Vanka, K., Arulmozhi, S., and Gonnade, R. G., “Rivaroxaban eutectics with improved solubility, dissolution rates, bioavailability and stability”, Crystengcomm, vol. 25, no. 22, pp. 3253-3263, 2023.
2022
T. R. Shaikh, George, C. P., Bhukya, P., Shelke, N., Pawar, K., Garai, A., Dandela, R., Gonnade, R. G., and Nangia, A. K., “Novel crystal forms of Entresto: a supramolecular complex of trisodium sacubitril/valsartan hemi-pentahydrate”, Crystengcomm, vol. 24, no. 42, pp. 7387-7393, 2022.
S. Pahar, Sharma, V., Mahata, B., George, C. P., Sharma, H., Vanka, K., and Sen, S. S., “Tridentate NacNac stabilized tin and nickel complexes: access to a monomeric nickel hydride and its catalytic application”, Inorganic Chemistry, vol. 61, no. 43, pp. 17370-17377, 2022.
2021
S. H. Thorat, George, C. P., Shaligram, P. S., Suresha, P. R., and Gonnade, R. G., “Polymorphs and hydrates of the anticancer drug erlotinib: X-ray crystallography, phase transition and biopharmaceutical studies”, CrystEngComm, vol. 23, no. 22, pp. 3961-3974, 2021.
2020
C. P. George, Sangtani, E., and Gonnade, R. G., “Crystal structure of a 1:1 co-crystal of the anti-cancer drug gefitinib with azelaic acid ”, Acta Crystallographica Section E: Crystallographic Communications, vol. 76, no. 6, pp. 884-888, 2020.
C. P. George, Thorat, S. H., Shaligram, P. S., Suresha, P. R., and Gonnade, R. G., “Drug-drug cocrystals of anticancer drugs erlotinib-furosemide and gefitinib-mefenamic acid for alternative multi-drug treatment”, Crystengcomm, vol. 22, no. 37, pp. 6137-6151, 2020.